This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eligo Bioscience. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jan Havranek: Innovator in Bacteria-Associated Disease Treatment
Introduction
Jan Havranek is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in the treatment of bacteria-associated diseases. His innovative approach has the potential to change the way such diseases are managed.
Latest Patents
Jan Havranek holds a patent for a method aimed at treating or preventing bacteria-associated diseases. This method involves modulating the ratio of bacteria from two newly identified categories: α-type and β-type. The α-type category is associated with acne strains, while the β-type includes non-acne-associated strains. This groundbreaking patent represents a significant advancement in the understanding and treatment of acne-related conditions. He has 1 patent to his name.
Career Highlights
Jan Havranek is currently associated with Eligo Bioscience, a company focused on developing innovative solutions in the field of microbiome research. His work at Eligo Bioscience has allowed him to explore new frontiers in the treatment of bacterial diseases, contributing to the company's mission of advancing health through microbiome science.
Collaborations
Due to space constraints, the details of Jan Havranek's collaborations will not be included.
Conclusion
Jan Havranek's contributions to the field of bacteria-associated disease treatment highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile